Immuno-Oncology Faculty
Christine Brown, Ph.D., is deputy director of the T Cell Therapeutics Research Laboratory at Beckman Research Institute of City of Hope.
Mingye Feng, Ph.D., is an associate professor in the Department of Immuno-Oncology
Stephen J. Forman, M.D., hematologist-oncologist, is a top cancer doctor for leukemia, lymphoma and bone marrow transplantation. He is also the director of the Hematologic Malignancies Research Institute & director of the T Cell Therapeutics Research Laboratory at City of Hope, Duarte, California.
Alex Herrera, M.D., is chief of the Division of Lymphoma and a hematologist-oncologist at City of Hope specializing in treating and researching lymphoma.
Marcin Kortylewski, Ph.D., is a professor in the Department of Immuno-Oncology, focuses on cancer immunotherapy.
Peter P. Lee, M.D., is professor and chair in the department of Immuno-Oncology, Beckman Research Institute of City of Hope in Southern California and beneficiary of The Christopher Family Endowed Innovation Fund for Alzheimer’s Disease and Breast Cancer Research in Honor of Vineta Christopher.
Edwin Manuel, Ph.D., is Assistant Professor in the Department of Immuno-Oncology.
Javier Gordon Ogembo, Ph.D., is associate professor in the Department of Immuno-Oncology at Beckman Research Institute of City of Hope.
Leo David Wang, M.D., Ph.D., is a pediatric hematologist-oncologist and associate professor in the departments of Immuno-Oncology and Pediatrics.
Hua Yu, Ph.D., associate chair of the Department of Immuno-Oncology, has made STAT3 the focus of much of her research.